Puma Biotechnology, Inc. (PBYI)

NMS – Real Time Price. Currency in USD

8.81

+0.04 (0.51%)

Market open: Aug 12, 2026, 1:05 PM EDT

8.43

-0.34 (-3.88%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

228M

230M

236M

228M

Cost of goods sold

-58M

-64M

-63M

-55M

Gross Profit

170M

166M

173M

Operating expenses (excl. COGS)

-133M

-135M

-140M

-142M

Operating Income

37M

31M

33M

31M

Non-operating income, total

-2M

-7M

-11M

-30M

Pretax income

36M

24M

23M

457K

Equity in earnings

Taxes

-5M

-1M

-455K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

31M

30M

22M

Discontinued operations

Net income

31M

30M

22M

Dilution adjustment

Preferred dividends

Puma Biotechnology, Inc. (PBYI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Puma Biotechnology, Inc. (PBYI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Puma Biotechnology, Inc. (PBYI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Puma Biotechnology, Inc. (PBYI)

Income Statement (Annual)

Income Statement (Annual)